Staphylococcal infection
MONDO:0024313An infection caused by Staphylococcus.
Also known as: staphylococcal infection
84 clinical trials for this condition and its sub-types, 41 tagged with Staphylococcal infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Staphylococcal infection
-
Staphylococcus aureus infection 37 trials · 69 incl. sub-types
7 sub-types
- Methicillin-resistant staphylococcus aureus infectious disease 19 trials
- Hordeolum 1 trial · 7 incl. sub-types Sub-types →
- Impetigo 5 trials Sub-types →
- Methicillin-susceptible staphylococcus aureus infectious disease 5 trials
- Staphylococcus aureus pneumonia 1 trial
- Staphylococcal scalded skin syndrome 0 trials
- Staphylococcus discitis 0 trials
-
Staphylococcal pneumonia 1 trial
1 sub-type
- Staphylococcus aureus pneumonia 1 trial
-
Staphylococcal toxemia 0 trials · 1 incl. sub-types
5 sub-types
- Staphylococcal toxic-shock syndrome 1 trial
- Bullous impetigo 0 trials
- Staphylococcal necrotizing pneumonia 0 trials
- Staphylococcal scalded skin syndrome 0 trials
- Staphylococcal scarlet fever 0 trials
-
Staphyloenterotoxemia 0 trials
Most studied deeper sub-types
-
Could a Parent's nose bacteria protect newborns from infection?
Disease control OngoingThis study tests whether giving a newborn a nasal microbiome transplant from their parent can increase the diversity of bacteria in the baby's nose. The goal is to see if this can help prevent infections like those caused by Staphylococcus aureus. The study involves 175 premature…
Phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Could a Parent's nose bacteria shield newborns from staph?
Disease control OngoingThis early study tests whether transferring a parent's healthy nasal bacteria to their newborn can help prevent staph infections. Researchers will give the baby a nasal spray containing the parent's bacteria or a placebo, then monitor the baby's nose bacteria and safety. The stud…
Phase 1 • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Common TB drug may fuel superbug resistance, study warns
Knowledge-focused OngoingThis study investigates whether taking rifampicin for latent tuberculosis increases the risk of antibiotic resistance in Staphylococcus aureus bacteria that naturally live on the skin. Researchers will compare people treated with rifampicin to those treated with isoniazid, taking…
Sponsor: Region Skane • Aim: Knowledge-focused
Last updated Jul 17, 2026 00:00 UTC
-
Tracking immune recovery after sepsis: clues to better outcomes
Knowledge-focused OngoingThis study looks at how the immune system bounces back in people who survive a severe bloodstream infection caused by Staphylococcus aureus bacteria. Researchers are measuring specific immune markers, like HLA-DR on monocytes, to see if recovery differs between people with and wi…
Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC